VEGFA increased in cells, mammary tumours and lung metastases derived from NFIB/Nfib‐overexpressing models and decreased upon ERO1A downregulation (Fig 5C and EV4A–D, Appendix Fig S6A–C). Here, VEGFA is linked to breast cancer.